These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15149035)

  • 41. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection.
    Suzuki K; Shinzawa N; Ishigaki K; Nakamura K; Abe H; Fukui-Miyazaki A; Ikuta K; Horiguchi Y
    Microbiol Immunol; 2017 Sep; 61(9):371-379. PubMed ID: 28752940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination.
    Gillard J; van Schuppen E; Diavatopoulos DA
    Adv Exp Med Biol; 2019; 1183():53-80. PubMed ID: 31432398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined transcriptomic and ChIPseq analyses of the
    Coutte L; Antoine R; Slupek S; Locht C
    mSystems; 2024 Apr; 9(4):e0095123. PubMed ID: 38470037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice.
    Feunou PF; Kammoun H; Debrie AS; Locht C
    Vaccine; 2014 Jul; 32(34):4281-8. PubMed ID: 24950361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pertussis: Where did we go wrong and what can we do about it?
    Locht C
    J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How Genomics Is Changing What We Know About the Evolution and Genome of Bordetella pertussis.
    Ring N; Abrahams JS; Bagby S; Preston A; MacArthur I
    Adv Exp Med Biol; 2019; 1183():1-17. PubMed ID: 31321755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of improved vaccines against whooping cough: current status.
    Marzouqi I; Richmond P; Fry S; Wetherall J; Mukkur T
    Hum Vaccin; 2010 Jul; 6(7):543-53. PubMed ID: 20448470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New pertussis vaccination approaches: en route to protect newborns?
    Locht C; Mielcarek N
    FEMS Immunol Med Microbiol; 2012 Nov; 66(2):121-33. PubMed ID: 22574832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neonatal Immunity to
    Argondizo-Correia C; Rodrigues AKS; de Brito CA
    J Immunol Res; 2019; 2019():7134168. PubMed ID: 30882004
    [No Abstract]   [Full Text] [Related]  

  • 50. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen.
    Mooi FR
    Infect Genet Evol; 2010 Jan; 10(1):36-49. PubMed ID: 19879977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Live attenuated vaccines against pertussis.
    Locht C; Mielcarek N
    Expert Rev Vaccines; 2014 Sep; 13(9):1147-58. PubMed ID: 25085735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined RNAseq and ChIPseq Analyses of the BvgA Virulence Regulator of Bordetella pertussis.
    Coutte L; Antoine R; Slupek S; Solans L; Derop J; Bonnefond A; Hot D; Locht C
    mSystems; 2020 May; 5(3):. PubMed ID: 32430408
    [No Abstract]   [Full Text] [Related]  

  • 54. Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection.
    Locht C; Papin JF; Lecher S; Debrie AS; Thalen M; Solovay K; Rubin K; Mielcarek N
    J Infect Dis; 2017 Jul; 216(1):117-124. PubMed ID: 28535276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model.
    Kavanagh H; Noone C; Cahill E; English K; Locht C; Mahon BP
    Clin Exp Allergy; 2010 Jun; 40(6):933-41. PubMed ID: 20184606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pertussis control: time for something new?
    Clark TA; Messonnier NE; Hadler SC
    Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.
    Hausman SZ; Burns DL
    Infect Immun; 2000 Jun; 68(6):3763-7. PubMed ID: 10816544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
    Bouchez V; Guiso N
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attenuated Bordetella pertussis BPZE1 protects against allergic airway inflammation and contact dermatitis in mouse models.
    Li R; Cheng C; Chong SZ; Lim AR; Goh YF; Locht C; Kemeny DM; Angeli V; Wong WS; Alonso S
    Allergy; 2012 Oct; 67(10):1250-8. PubMed ID: 22909095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.